Literature DB >> 28783024

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey.

Ahmet Arvas1, Haluk Çokuğraş1, Emel Gür1, Nevriye Gönüllü2, Zeynep Taner2, Hrisi Bahar Tokman2.   

Abstract

AIMS: To determine the prevalence of nasopharyngeal carriage of Streptococcus pneumoniae in healthy children aged 0-6 years who were vaccinated with pneumococcal conjugate vaccine.
METHODS: This cross-sectional study was conducted on 150 healthy Turkish children between 1 month and 6 years of age. Serotyping was performed and risk factors of carriage were evaluated.
RESULTS: The overall carriage rate was 14%. Vaccine type serotypes were determined in 17 (12.6%) children who received full-dose PCV13 vaccine. The highest carriage rate was observed among children younger than 24 months (76.2%). In multivariate analysis, respiratory infection in recent months, age, attendance at a day-care center and antibiotic usage were not statistically significant risk factors for carriage. Overall, S. pneumoniae strains were considered as penicillin susceptible and antimicrobial resistance was limited.
CONCLUSION: We observed a low rate of pneumococcal carriage in children after PCV13 implementation compared with that of children receiving PCV7. Although it was reduced, vaccine serotype colonization in PCV13-vaccinated children remains persistent.

Entities:  

Keywords:  Children; nasopharyngeal carriage; pneumococcal conjugate vaccine Streptococcus pneumoniae.

Mesh:

Substances:

Year:  2017        PMID: 28783024      PMCID: PMC5615970          DOI: 10.4274/balkanmedj.2016.1256

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  19 in total

1.  Comparison of the Denka Seiken slide agglutination method to the quellung test for serogrouping of Streptococcus pneumoniae isolates.

Authors:  Cheryl K Shutt; Matthew Samore; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.

Authors:  Ron Dagan; Scott Patterson; Christine Juergens; David Greenberg; Noga Givon-Lavi; Nurith Porat; Alejandra Gurtman; William C Gruber; Daniel A Scott
Journal:  Clin Infect Dis       Date:  2013-06-26       Impact factor: 9.079

3.  Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts.

Authors:  Grace M Lee; Ken Kleinman; Stephen I Pelton; William Hanage; Susan S Huang; Matthew Lakoma; Maya Dutta-Linn; Nicholas J Croucher; Abbie Stevenson; Jonathan A Finkelstein
Journal:  J Pediatric Infect Dis Soc       Date:  2013-10-03       Impact factor: 3.164

4.  Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece.

Authors:  Ioanna N Grivea; Kostas N Priftis; Apostolos Giotas; Doxa Kotzia; Alexandra G Tsantouli; Konstantinos Douros; Aspasia N Michoula; George A Syrogiannopoulos
Journal:  Vaccine       Date:  2014-09-22       Impact factor: 3.641

5.  Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-09-16       Impact factor: 17.586

6.  Risk factors for nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of heptavalent pneumococcal conjugate vaccine (PCV7) to the national vaccine schedule.

Authors:  Halil Özdemir; Ergin Çiftçi; Rıza Durmaz; Haluk Güriz; Ahmet Derya Aysev; Adem Karbuz; Refik Gökdemir; Bülent Acar; Selin Nar-Ötgün; Mustafa Ertek; Serdal Kenan Köse; Erdal İnce
Journal:  Turk J Pediatr       Date:  2013 Nov-Dec       Impact factor: 0.552

7.  Radical serotype rearrangement of carried pneumococci in the first 3 years after intensive vaccination started in Hungary.

Authors:  Adrienn Tóthpál; Szilvia Kardos; Krisztina Laub; Károly Nagy; Tamás Tirczka; Mark van der Linden; Orsolya Dobay
Journal:  Eur J Pediatr       Date:  2014-09-02       Impact factor: 3.183

8.  Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations.

Authors:  M Hackel; C Lascols; S Bouchillon; B Hilton; D Morgenstern; J Purdy
Journal:  Vaccine       Date:  2013-08-06       Impact factor: 3.641

9.  Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.

Authors:  Ismar A Rivera-Olivero; Berenice Del Nogal; Mariana Fuentes; Rossana Cortez; Debby Bogaert; Peter W M Hermans; Jacobus H de Waard
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

10.  Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England.

Authors:  K E Chapman; D Wilson; R Gorton
Journal:  Epidemiol Infect       Date:  2012-05-08       Impact factor: 4.434

View more
  2 in total

1.  Nasal colonization by potential bacterial pathogens in healthy kindergarten children of Nepal: a prevalence study.

Authors:  Govinda Paudel; Neetu Amatya; Bhuvan Saud; Sunita Wagle; Vikram Shrestha; Bibhav Adhikari
Journal:  Germs       Date:  2022-03-31

2.  Characterization of Pneumococcal Colonization Dynamics and Antimicrobial Resistance Using Shotgun Metagenomic Sequencing in Intensively Sampled South African Infants.

Authors:  Rendani I Manenzhe; Felix S Dube; Meredith Wright; Katie Lennard; Stephanie Mounaud; Stephanie W Lo; Heather J Zar; William C Nierman; Mark P Nicol; Clinton Moodley
Journal:  Front Public Health       Date:  2020-09-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.